Complementary medicine for fatigue and cortisol variability in breast cancer survivors: a randomized controlled trial (Q44968245)

7 December 2017

Complementary medicine for fatigue and cortisol variability in breast cancer survivors: a randomized controlled trial (English)

1 reference

7 December 2017

0 references

9

Scott C Roesch

1 reference

7 December 2017

Shamini Jain

1

1 reference

7 December 2017

Desiree Pavlik

2

1 reference

7 December 2017

Janet Distefan

3

1 reference

7 December 2017

Rosalyn L Bruyere

4

1 reference

7 December 2017

Julia Acer

5

1 reference

7 December 2017

Rosalie Garcia

6

1 reference

7 December 2017

Ian Coulter

7

1 reference

7 December 2017

John Ives

8

1 reference

7 December 2017

Wayne Jonas

10

1 reference

7 December 2017

Paul J Mills

11

1 reference

7 December 2017

language of work or name

English

0 references

publication date

5 August 2011

1 reference

7 December 2017

1 reference

7 December 2017

118

1 reference

7 December 2017

3

1 reference

7 December 2017

777-787

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.26345

7 December 2017

1 reference

Fatigue in long-term breast carcinoma survivors: a longitudinal investigation

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.26345

Fatigue, depression and quality of life in cancer patients: how are they related?

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.26345

Diurnal cortisol dysregulation, functional disability, and depression in women with ovarian cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.26345

Diurnal cortisol rhythm and fatigue in breast cancer survivors

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.26345

Flattened cortisol rhythms in metastatic breast cancer patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.26345

Large-core breast biopsy: abnormal salivary cortisol profiles associated with uncertainty of diagnosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.26345

Erythropoietin use in oncology: a summary of the evidence and practice guidelines comparing efforts of the Cochrane Review group and Blue Cross/Blue Shield to set up the ASCO/ASH guidelines

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.26345

Differential effects of paroxetine on fatigue and depression: a randomized, double-blind trial from the University of Rochester Cancer Center Community Clinical Oncology Program

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.26345

Effect of paroxetine hydrochloride (Paxil) on fatigue and depression in breast cancer patients receiving chemotherapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.26345

The effect of modafinil on cognitive function in breast cancer survivors

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.26345

Integrative nonpharmacologic behavioral interventions for the management of cancer-related fatigue

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.26345

Systematic review and meta-analysis of psychological and activity-based interventions for cancer-related fatigue.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.26345

Controlled physical activity trials in cancer survivors: a systematic review and meta-analysis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.26345

The role of education in managing fatigue, anxiety, and sleep disorders in women undergoing chemotherapy for breast cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.26345

Use of alternative medicine by women with early-stage breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.26345

Use of complimentary and alternative medicine by breast cancer patients: prevalence, patterns and communication with physicians

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.26345

The RAND 36-Item Health Survey 1.0.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.26345

Further validation of the multidimensional fatigue symptom inventory-short form

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.26345

Measurement of depressive symptoms in cancer patients: evaluation of the Center for Epidemiological Studies Depression Scale (CES-D).

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.26345

Reliability and validity of the Functional Assessment of Cancer Therapy-Breast quality-of-life instrument.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.26345

Salivary cortisol in psychobiological research: an overview

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.26345

Salivary cortisol on ROCHE Elecsys immunoassay system: pilot biological variation studies

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.26345

A randomized controlled trial of mindfulness meditation versus relaxation training: effects on distress, positive states of mind, rumination, and distraction.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.26345

Move over ANOVA: progress in analyzing repeated-measures data and its reflection in papers published in the Archives of General Psychiatry

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.26345

The relationship between fatigue and quality of life and inflammation during anthracycline-based chemotherapy in breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.26345

Fatigue and proinflammatory cytokine activity in breast cancer survivors

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.26345

Baseline quality of life as a prognostic indicator of survival: a meta-analysis of individual patient data from EORTC clinical trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.26345

Changes in health-related quality of life may predict recurrent breast cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.26345

Preservation of immune function in cervical cancer patients during chemoradiation using a novel integrative approach.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.26345

Diurnal cortisol rhythm as a predictor of breast cancer survival

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.26345

7 January 2021

Patient-controlled methylphenidate for cancer fatigue: a double-blind, randomized, placebo-controlled trial

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.26345

7 January 2021

Randomized Controlled Trial of an Educational Intervention for Managing Fatigue in Women Receiving Adjuvant Chemotherapy for Early-Stage Breast Cancer

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.26345

7 January 2021

A randomized clinical trial of energy conservation for patients with cancer-related fatigue

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.26345

7 January 2021

A multidimensional measure of fatigue for use with cancer patients

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.26345

7 January 2021

Identifiers

DOI

10.1002/CNCR.26345

1 reference

7 December 2017

1 reference